Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DU60ND
|
|||
| Drug Name |
Ofranergene obadenovec
|
|||
| Synonyms |
VB-111
Click to Show/Hide
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 3 | [1] | |
| Glioblastoma of brain [ICD-11: 2A00.00; ICD-10: C71] | Phase 2 | [2] | ||
| Company |
VBL Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03398655) A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT04406272) VB-111 in Surgically Accessible Recurrent/Progressive GBM. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.